DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
Add Tribune As Your Trusted Source
search-icon-img
search-icon-img
Advertisement

OMRON Healthcare Surpasses 50 Million Nebulizers Sold

  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

KYOTO, Japan, Nov. 28, 2025 /Kyodo JBN/ --

Advertisement

- Easing Burden of Respiratory Diseases Worldwide since 1978 -

Advertisement

OMRON HEALTHCARE Co., Ltd., a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, announced that cumulative sales of its nebulizers have surpassed 50 million units. This proud milestone underscores the company’s long-standing commitment to helping people around the world to live healthier lives through management of respiratory conditions.

Advertisement

Image1: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI1fl_gvhJ3KRi.png

Internationally, respiratory diseases are a growing issue, particularly in emerging economies. According to the World Health Organization, some 339 million people suffer from asthma worldwide, with an estimated 3.5 million deaths each year due to Chronic Obstructive Pulmonary Disorder (COPD). Nebulizers, which convert liquid medications into a fine mist that can be inhaled directly into the lungs, are a key tool for easing the burden of respiratory diseases in children and adults alike.

Advertisement

Almost five decades as a trusted partner in respiratory therapy

Since the launch of its first nebulizer in 1978, OMRON Healthcare has pioneered the development of compact home-use devices that deliver medical-grade respiratory treatment outside of clinical settings, prioritizing ease of use for families and patients of all ages, from young children to older adults.

Image2: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI2fl_5D7pQUoU.png

Design landmarks ranging from the first ultrasonic models to portable mesh-type and low-noise compressor technologies have made medication delivery more consistent and convenient for millions of users worldwide, including those living with chronic and acute respiratory ailments such as asthma, COPD, RSV bronchitis, cystic fibrosis, and a range of physical disabilities.

Image3: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI3fl_C3N67qeX.png

Comment from Tomohiro Kukita, Senior Manager, Product Planning Strategy HQ of OMRON HEALTHCARE Co., Ltd.: https://kyodonewsprwire.jp/attach/202510308084-O1-S6J3q6El.pdf

About OMRON Healthcare: https://kyodonewsprwire.jp/attach/202510308084-O2-W1MisE02.pdf

For more information, please visit:

Website: https://healthcare.omron.com/

LinkedIn: https://www.linkedin.com/company/omron-healthcare-co-ltd-/

Source: OMRON HEALTHCARE Co., Ltd.

(Disclaimer: The above press release comes to you under an arrangement with Asianet and PTI takes no editorial responsibility for the same.). PTI

(This content is sourced from a syndicated feed and is published as received. The Tribune assumes no responsibility or liability for its accuracy, completeness, or content.)

Advertisement
Advertisement
Advertisement
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts